ICLR: ICON Plc Price-to-Revenue Coefficient

Corporate company logo of ICON Corp (ICLR)

The stability of ICON Public is based on serving a diverse client base, which mitigates the risks associated with individual failed trials. The company's price/sales multiple clearly illustrates the link between market value and actual revenues, with 1.80 serving as the current value of this metric. Business efficiency is increasing through AI-driven data collection automation and the continuous modernization of global laboratory infrastructure.

ICLR ICON Plc: Price-to-Revenue Ratio in the range 07/04/2022 - 11/13/2026

ICON Plc (ICLR) - metric breakdowns and financial figures

- price and consensus price forecast:
Market Chart ICON plc|ICLR - Analyst Consensus Forecast
- market capitalization information:
Market Capitalization ICON Plc|ICLR - Enterprise Value
- company book value details:
Accounting Value per Share ICON|ICLR - Company Book Value|Market-to-Book Ratio iconplc.com|ICLR - Aggregate Company Assets
- debt obligations and liquidity statistics:
Debt to Equity Ratio ICON Public|ICLR - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital ICON Corp|ICLR - Company Debts|Debts to Book Capitalization Ratio ICON Plc|ICLR - Company Long-Term Liabilities|Company Short-Term Debts ICON|Quick Liquidity iconplc.com
- business earnings and investment ratios data:
ICLR - Company Net Income|Expected Profit ICON Public|ICLR - P/E Multiple|Market Cap to Projected Earnings ICON|ICLR - PEG Multiple|Enterprise Value to EBITDA Ratio ICON Plc|ICLR - Operating profit EBITDA|Net earnings per share for the last four quarters ICON|ICLR - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months iconplc.com|ICLR - Earnings per share growth in current year|Net earnings per share growth forecast for next year ICON Public
- total revenue and sales volume data:
ICLR - Company Revenue|Company Future Revenue ICON Plc|ICLR - Price-to-Revenue Ratio|Future Price to Revenue ICON Plc
Fundamental company analysis:iconplc.com - ICLR
Manufactured products of ICON Plc

ICON Public's leading position in the contract clinical research sector and long-term contracts with pharmaceutical behemoths create a stable foundation for revenue generation. Constant monitoring of the company's P/S ratio allows for the correlation of the business's market value with actual sales volume, where an inflated multiple signals an overvaluation of the asset and risks of correction should revenue growth rates slow.

Who ICON Public competes with

Price-to-Revenue Coefficient iqvia.com|P/S Multiple LH (Labcorp)|Price-to-Revenue Coefficient Medpace Holdings (MEDP)|Charles River Lab - P/S Multiple|Evotec Group (EVO) - Market Cap to Revenue|Fortrea Holdings Inc. (FTRE) - Price-to-Revenue Ratio|Price to Sales Lifecore Biomedical, Inc. (LFCR)|Price-to-Revenue Ratio OmniAb|Market Cap to Revenue Ratio NOTV (Inotiv Inc)|Market Cap to Revenue CDMO (Avid Bioservices, Inc)|CTLT (Catalent, Inc) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Scorpius Holdings, Inc. SCPX